116 related articles for article (PubMed ID: 28225497)
1. Analysis of risk factors in patients with leukoaraiosis.
Guan J; Yan C; Gao Q; Li J; Wang L; Hong M; Zheng X; Song Z; Li M; Liu M; Fan Y; Ma L
Medicine (Baltimore); 2017 Feb; 96(8):e6153. PubMed ID: 28225497
[TBL] [Abstract][Full Text] [Related]
2. The association of uric acid with leukoaraiosis.
Li JJ; Huang YH; Lin YY; Li MM; Chen YF; Cai RW
J Int Med Res; 2017 Feb; 45(1):75-81. PubMed ID: 27913745
[TBL] [Abstract][Full Text] [Related]
3. Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension.
Gamil S; Erdmann J; Schwedhelm E; Bakheit KH; Abdalrahman IBB; Mohamed AO
Kidney Blood Press Res; 2020; 45(5):727-736. PubMed ID: 32814314
[TBL] [Abstract][Full Text] [Related]
4. S100B and ADMA in cerebral small vessel disease and cognitive dysfunction.
Gao Q; Fan Y; Mu LY; Ma L; Song ZQ; Zhang YN
J Neurol Sci; 2015 Jul; 354(1-2):27-32. PubMed ID: 25990800
[TBL] [Abstract][Full Text] [Related]
5. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
Stühlinger MC; Abbasi F; Chu JW; Lamendola C; McLaughlin TL; Cooke JP; Reaven GM; Tsao PS
JAMA; 2002 Mar; 287(11):1420-6. PubMed ID: 11903029
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine in cerebral small vessel disease.
Khan U; Hassan A; Vallance P; Markus HS
Stroke; 2007 Feb; 38(2):411-3. PubMed ID: 17204687
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of asymmetric dimethylarginine (ADMA) levels in children with growth hormone deficiency.
Önder A; Aycan Z; Koca C; Ergin M; Çetinkaya S; Ağladıoğlu SY; Peltek Kendirci HN; Baş VN
J Clin Res Pediatr Endocrinol; 2014; 6(1):22-7. PubMed ID: 24637306
[TBL] [Abstract][Full Text] [Related]
8. Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke.
Ercan M; Mungan S; Güzel I; Celik HT; Bal C; Abusoglu S; Akbulut D; Oguz EF; Yilmaz FM
Adv Clin Exp Med; 2019 May; 28(5):693-698. PubMed ID: 30170483
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of leukoaraiosis from 4683 hospitalized patients: A cross-sectional study.
Lin Q; Huang WQ; Ma QL; Lu CX; Tong SJ; Ye JH; Lin HN; Gu L; Yi KH; Cai LL; Tzeng CM
Medicine (Baltimore); 2017 Sep; 96(39):e7682. PubMed ID: 28953609
[TBL] [Abstract][Full Text] [Related]
10. [Age features of pure leukoaraiosis in non-demented outpatients].
Yu XY; Wang GH; Guan XT; Liu Y; Wang SX; Liu ZZ; Wang YJ
Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):488-90. PubMed ID: 20979735
[TBL] [Abstract][Full Text] [Related]
11. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
[TBL] [Abstract][Full Text] [Related]
12. Apparently "low" serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes.
Onat A; Köroğlu B; Can G; Karagöz A; Yüksel M; Aydın M
Anadolu Kardiyol Derg; 2014 Feb; 14(1):26-33. PubMed ID: 24342929
[TBL] [Abstract][Full Text] [Related]
13. Serum Apelin and Asymmetric Dimethylarginine Levels in Patients With Exfoliation Syndrome or Exfoliative Glaucoma.
Bezci Aygun F; Kocabeyoglu S; Irkec M; Dikmen ZG; Umaroglu MM; Konstas AGP
J Glaucoma; 2020 Jul; 29(7):593-597. PubMed ID: 32287143
[TBL] [Abstract][Full Text] [Related]
14. The relationship between serum asymmetric dimethylarginine levels and subjective sleep quality in normotensive patients with type 2 diabetes mellitus.
Aribas A; Kayrak M; Tekinalp M; Akilli H; Alibasic H; Yildirim S; Gunduz M; Taner A; Unlu A
Korean J Intern Med; 2015 May; 30(3):316-24. PubMed ID: 25995662
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke.
Nishiyama Y; Ueda M; Katsura K; Otsuka T; Abe A; Nagayama H; Katayama Y
J Neurol Sci; 2010 Mar; 290(1-2):12-5. PubMed ID: 20060545
[TBL] [Abstract][Full Text] [Related]
16. The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus.
Taner A; Unlu A; Kayrak M; Tekinalp M; Ayhan SS; Arıbaş A; Erdem SS
Atherosclerosis; 2013 Jun; 228(2):432-7. PubMed ID: 23540293
[TBL] [Abstract][Full Text] [Related]
17. Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression.
Testa A; Mallamaci F; Leonardis D; Spoto B; Pisano A; Sanguedolce MC; Tripepi G; Zoccali C;
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):167-72. PubMed ID: 25435339
[TBL] [Abstract][Full Text] [Related]
18. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease.
Kielstein JT; Böger RH; Bode-Böger SM; Frölich JC; Haller H; Ritz E; Fliser D
J Am Soc Nephrol; 2002 Jan; 13(1):170-176. PubMed ID: 11752034
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients.
Locsey L; Seres I; Sztanek F; Harangi M; Padra J; Kovacs D; Fedor R; Asztalos L; Paragh G
Transplant Proc; 2013; 45(10):3685-7. PubMed ID: 24314997
[TBL] [Abstract][Full Text] [Related]
20. Are increased oxidative stress and asymmetric dimethylarginine levels associated with masked hypertension?
Inan B; Ates I; Ozkayar N; Kundi H; Topcuoglu C; Dede F; Sennaroglu E
Clin Exp Hypertens; 2016; 38(3):294-8. PubMed ID: 27018581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
